Table 3.
Complications | CV disease | DPN | LEAD | DN | DR |
95% CI | −1.47 to –0.22 | −1.06 to 0.31 | −1.44 to –0.29 | −0.73 to 0.45 | −1.24 to 0.15 |
P value | 0.008 | 0.283 | 0.004 | 0.639 | 0.123 |
Glucose | 0 min | 30 min | 60 min | 120 min | 180 min |
r | −0.121 | −0.146 | −0.162 | −0.287 | −0.313 |
P value | 0.109 | 0.071 | 0.045 | <0.001 | <0.001 |
C peptide | 0 min | 30 min | 60 min | 120 min | 180 min |
r | −0.006 | −0.004 | 0.046 | 0.106 | 0.086 |
P value | 0.942 | 0.959 | 0.575 | 0.191 | 0.287 |
Correlations are shown with the coefficient r or 95% Cl of the mean difference between the patients with complications and without.
Cre/CysC, creatinine to cystatin C ratio; CV, cardiovascular; DN, diabetic nephropathy; DPN, diabetic peripheral neuropathy; DR, diabetic retinopathy; LEAD, lower-extremity arterial disease.